http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106855575-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate | 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106855575-B |
| titleOfInvention | A kind of three quick detection kit of breast cancer |
| abstract | The invention belongs to field of biological detection, and in particular to a kind of three quick detection kit of breast cancer of tumour serum mark CA125, HE4 and P-her2.Three quick detection kit of breast cancer provided by the invention is mainly made of abzyme target, biotin antibody coating plate, serum dilution, horseradish peroxidase, tetramethyl benzidine, hydrochloric acid, negative controls and positive control solution.Three quick detection kit of breast cancer provided by the invention can detecte the expression of patient or recurrence and metastatic tumo(u)r patient's body CA125, HE4 and P-her2 after operative treatment, be of great significance to the clinical diagnosis of breast cancer.Meanwhile three quick detection kit of breast cancer provided by the invention can reduce the interference of other substances in serum, greatly improve the Stability and veracity of testing result, be conducive to the early diagnosis and pre- post-processing of patient with breast cancer. |
| priorityDate | 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.